An infographic that explains the concept of robust worldwide patient exposure. It has a blue background with white text. The title of the infographic is "Robust Worldwide Patient Exposure" and it mentions that Exalgo was studied in 14 clinical trials and 2474 patients and 1483 patients were exposed to a dose of 32 mg or greater.
Below the title there is an image of a woman with long dark hair smiling and looking up at the sky. She is holding her head with one hand and has her other hand on her chin as if she is deep in thought. The text on the infographic explains that the exposure was not metabolized by cytoplasm therefore it may reduce the potential for certain drug interactions in patients taking multiple medications.
Description 
Type
Category
Source 1 of 3
-
Date
2012
Collection
-
Date
2012
Collection
-
Date
2012
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
